The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Evaluation of a Pharmacist-Led Medication Assessment Used to Identify Prevalence of and Associations With Polypharmacy and Potentially Inappropriate Medication Use Among Ambulatory Senior Adults With Cancer
Open accessAbstract
Purpose: The use of multiple and/or inappropriate medications in seniors is a significant public health problem, and cancer treatment escalates its prevalence and complexity. Existing studies are limited by patient self-report and medical record extraction compared with a pharmacist-led comprehensive medication assessment. Patients and Methods: We retrospectively examined medication use in ambulatory senior adults with cancer to determine the prevalence of polypharmacy (PP) and potentially inappropriate medication (PIM) use and associated factors. PP was defined as concurrent use of five or more and less than 10 medications, and excessive polypharmacy (EPP) was defined as 10 or more medications. PIMs were categorized by 2012 Beers Criteria, Screening Tool of Older Person's Prescriptions (STOPP), and the Healthcare Effectiveness Data and Information Set (HEDIS). Results: A total of 248 patients received a geriatric oncology assessment between January 2011 and June 2013 (mean age was 79.9 years, 64% were women, 74% were white, and 87% had solid tumors). Only 234 patients (evaluated by pharmacists) were included in the final analysis. Mean number of medications used was 9.23. The prevalence of PP, EPP, and PIM use was 41% (n = 96), 43% (n = 101), and 51% (n = 119), respectively. 2012 Beers, STOPP, and HEDIS criteria classified 173 occurrences of PIMs, which were present in 40%, 38%, and 21% of patients, respectively. Associations with PIM use were PP (P < .001) and increased comorbidities (P = .005). Conclusion: A pharmacist-led comprehensive medication assessment demonstrated a high prevalence of PP, EPP, and PIM use. Medication assessments that integrate both 2012 Beers and STOPP criteria and consider cancer diagnosis, prognosis, and cancer-related therapy are needed to optimize medication use in this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toxicity and response criteria of the Eastern Cooperative Oncology Group
Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., & Carbone, P. P. (1982) · AMERICAN JOURNAL OF CLINICAL ONCOLOGY · doi:10.1097/00000421-198212000-00014 · Cited by 11,647
The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03923.x · Cited by 2,578
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
Smith, B. D., Smith, G. L., Hurria, A., Hortobagyi, G. N., & Buchholz, T. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.8983 · Cited by 1,721
Polypharmacy in elderly patients
Hajjar, E. R., Cafiero, A. C., & Hanlon, J. T. (2007) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2007.12.002 · Cited by 1,265
Self-citationManagement of Cancer in the Older Person: A Practical Approach
Balducci, L., & Extermann, M. (2000) · The Oncologist · doi:10.1634/theoncologist.5-3-224 · Cited by 939
Comprehensive geriatric assessment for older patients with cancer
Extermann, M., & Hurria, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.6559 · Cited by 875
Role of Pharmacist Counseling in Preventing Adverse Drug Events After Hospitalization
Schnipper, J. L., Kirwin, J. L., Cotugno, M. C., Wahlstrom, S. A., Brown, B. A., Tarvin, E., Kachalia, A., Horng, M., Roy, C. L., McKean, S. C., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.5.565 · Cited by 794
Gallagher, P., & O'Mahony, D. (2008) · Age and Ageing · doi:10.1093/ageing/afn197 · Cited by 697
Posthospital Medication Discrepancies: Prevalence and Contributing Factors
Coleman, E. A., Smith, J. D., Raha, D., & Min, S.-J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.16.1842 · Cited by 696
Hamilton, H., Gallagher, P., Ryan, C., Byrne, S., & O’Mahony, D. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.215 · Cited by 566
Reconcilable differences: correcting medication errors at hospital admission and discharge
Vira, T. (2006) · Quality and Safety in Health Care · doi:10.1136/qshc.2005.015347 · Cited by 449
Drug interactions in cancer therapy
Scripture, C. D., & Figg, W. D. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1887 · Cited by 366
Potential Drug Interactions and Duplicate Prescriptions Among Cancer Patients
Riechelmann, R. P., Tannock, I. F., Wang, L., Saad, E. D., Taback, N. A., & Krzyzanowska, M. K. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk130 · Cited by 328
Impact of a Pharmacist-Facilitated Hospital Discharge Program: A Quasi-Experimental Study
Walker, P. C. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.398 · Cited by 227
Factors Leading to Excessive Polypharmacy
Hovstadius, B., & Petersson, G. (2012) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2012.01.001 · Cited by 195
STOPP & START criteria: A new approach to detecting potentially inappropriate prescribing in old age
O’Mahony, D., Gallagher, P., Ryan, C., Byrne, S., Hamilton, H., Barry, P., O’Connor, M., & Kennedy, J. (2010) · European Geriatric Medicine · doi:10.1016/j.eurger.2010.01.007 · Cited by 188
Prithviraj, G. K., Koroukian, S. M., Margevicius, S. P., Berger, N. A., Bagai, R. K., & Owusu, C. (2012) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2012.02.005 · Cited by 154
Overcoming Problems with Polypharmacy and Drug Misuse in the Elderly
Montamat, S. C., & Cusack, B. J. (1992) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30503-2 · Cited by 151
Sokol, K. C., Knudsen, J. F., & Li, M. M. (2007) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2007.00815.x · Cited by 138
Murphy, E. M., Oxencis, C. J., Klauck, J. A., Meyer, D. A., & Zimmerman, J. M. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080552 · Cited by 129
Potential Drug Interactions in Cancer Patients Receiving Supportive Care Exclusively
Riechelmann, R. P., Zimmermann, C., Chin, S. N., Wang, L. E., O'Carroll, A., Zarinehbaf, S., & Krzyzanowska, M. K. (2008) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2007.06.009 · Cited by 125
Medication Problems in Older, Newly Diagnosed Cancer Patients in Canada: How Common are They?
Puts, M. T. E., Costa-Lima, B., Monette, J., Girre, V., Wolfson, C. M., Batist, G., & Bergman, H. (2009) · Drugs & Aging · doi:10.2165/00002512-200926060-00008 · Cited by 95
Ponniah, A. P., Anderson, B. A., Shakib, S., Doecke, C. J., & Angley, M. T. (2007) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2007.00827.x · Cited by 80
Setter, S. M., Corbett, C. F., Neumiller, J. J., Gates, B. J., Sclar, D. A., & Sonnett, T. E. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080582 · Cited by 68
Quality Patient Care and Pharmacists' Role in Its Continuity—A Systematic Review
Ellitt, G. R., Brien, J.-A. E., Aslani, P., & Chen, T. F. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1l505 · Cited by 44
藤田, 至. (2006) · Mebio oncology · Cited by 24
Cited by
What is polypharmacy? A systematic review of definitions
Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. E. (2017) · BMC Geriatrics · doi:10.1186/s12877-017-0621-2 · Cited by 3,293
Mohile, S. G., Dale, W., Somerfield, M. R., Schonberg, M. A., Boyd, C. M., Burhenn, P. S., Canin, B., Cohen, H. J., Holmes, H. M., Hopkins, J. O., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.8687 · Cited by 1,479
Kadambi, S., Loh, K. P., Dunne, R., Magnuson, A., Maggiore, R., Zittel, J., Flannery, M., Inglis, J., Gilmore, N., Mohamed, M., et al. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0421-z · Cited by 149
Trevino, K. M., Stern, A., Hershkowitz, R., Kim, S. Y., Li, Y., Lachs, M., & Prigerson, H. G. (2021) · Palliative and Supportive Care · doi:10.1017/s1478951521000286 · Cited by 23
“In addition to this dyadic effect, MAC was associated with greater reductions in anxiety in OACs and caregivers, respectively relative to usual care.”
BackgroundInfluential
Metadata
- Authors
- Nightingale, G., Hajjar, E., Swartz, K., Andrel-Sendecki, J., & Chapman, A.
- Venue
- Journal of Clinical Oncology
- Published
- 2015-05-01
- Volume
- 33
- Issue
- 13
- Pages
- 1453-1459
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2142503919
- Cited by
- 263
- References
- 26
- FWCI
- 14.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.